Tag: 5.7M
-
Avenue Biosciences raises $5.7M to scale high-throughput protein engineering
Finnish protein engineering company Avenue Biosciences has raised $5.7 million in a Seed extension funding round co-led by Balnord and Tesi, with support from existing investors Voima Ventures, Inventure, University of Helsinki, and Dimerent. The funding aims to help scale its high-throughput protein engineering technology that accelerates the discovery of protein-based therapies and tools for read more
Written by
